Research News and Research

RSS

Natural glucose byproduct prevents brain damage and cognitive impairment after diabetic coma

A natural, non-toxic byproduct of glucose may prevent brain cell death and cognitive impairment in diabetics following an episode of severely low blood sugar, according to researchers at the San Francisco VA Medical Center (SFVAMC).

27 Apr 2005

Patients' lives at risk from substandard drugs say heart specialists

Global action is needed to counter the dangers of substandard life-saving drugs that are putting patients' lives and health at risk, according to heart specialists writing in the new (19 April) issue of Europe's leading cardiology journal, the European Heart Journal.

27 Apr 2005

Increased risk associated with combining carotid artery, coronary artery surgeries

Among patients undergoing evaluation for coronary artery bypass surgery, stroke neurologists are frequently consulted when the patient also has severe carotid artery stenosis (blockage of an artery that supplies blood to the brain).

27 Apr 2005

Moderate hypothermia is a safe treatment following traumatic brain injury in children

A first-of-its-kind multi-center trial has shown that cooling the body can have positive affects on children who suffered traumatic brain injury.

27 Apr 2005

National study to evaluate the effectiveness Targacept

Wake Forest University School of Medicine is one of 15 centers nationwide recruiting participants for a research study to evaluate the effectiveness of an investigational drug as an oral treatment for age associated memory impairment (AAMI), a condition that is marked by memory loss and poor concentration.

27 Apr 2005

First steps towards building a mind-reading device

University College London (UCL) scientists have made the first steps towards building a mind-reading device. In a study published in the latest issue of Nature Neuroscience, the UCL team discovered that they could use brief recordings of brain activity alone to predict which of two objects volunteers were viewing.

27 Apr 2005

National clinical trial examines new option for kidney cancer patients

The trial, which opened last September, offers research subjects who qualify a new, targeted therapy in addition to standard immune therapy. The drug combination is being studied in a national Phase II clinical trial led by OHSU Cancer Institute researcher Christopher Ryan, M.D., through the Southwest Oncology Group, one of the largest clinical trial cooperative groups in the United States.

27 Apr 2005

Alcohol-impaired driving on the increase

A national survey has found that after a long, slow downward trend alcohol-impaired driving has recently increased significantly. From 1993 to 1997 the estimated annual number of episodes of alcohol-impaired driving (AID) declined at a rate of a little more than one percent per year, from 123 million to 116 million.

27 Apr 2005

Male therapists are just as likely as female therapists to encourage patients to admit infidelities

“Contrary to the perception that male counselors are less likely to reveal infidelity, because men in our society have more liberal attitudes about affairs and are more likely to have had them, that did not turn out to be the case in our study,” said Rosaria Carlone Upchurch, who did the research for her doctoral dissertation in counselor education.

27 Apr 2005

New, bigger low-carb potato with different taste will give consumers more choices

Following the January debut of the first low-carb potato that’s now a popular item in supermarkets, University of Florida researchers say a larger and tastier version of the spud will be available to consumers in May of this year.

27 Apr 2005

Promising new West Nile therapy cures disease in mice

West Nile virus alarmed Americans when it made its first U.S. appearance in New York City in 1999. It has since spread from coast to coast, sickened more than 16,000 Americans and killed more than 600.

27 Apr 2005

Report reveals urgent need to improve physical health of people with Schizophrenia

People with schizophrenia often die prematurely. However researchers from the University of Glasgow and NHS Greater Glasgow assert that much of the excess mortality of schizophrenia is preventable through lifestyle changes and the treatment of common diseases.

27 Apr 2005

Isotopes for society

The nucleus of an atom contains protons and neutrons. However, some atoms of the same chemical element can have varying numbers of neutrons, giving so-called isotopes of that element.

27 Apr 2005

Portable device to check for concussions

A player just took a hard knock to the head and is lying on the field. A coach rushes to his side, but the player sits up and seems fine.

27 Apr 2005

Quintuplets born to surrogate mother

In what is believed to be a world first, a surrogate mother has given birth to quintuplets.

26 Apr 2005

The power of advertising means you may get medications you don't need

A study published this month confirms what has often been suspected, that prescription drug advertising not only persuades patients to ask for certain medications but also has a profound influence on what doctors prescribe.

26 Apr 2005

Guidelines for research involving human embryonic stem cells

The National Academies today recommended guidelines for research involving human embryonic stem cells, and urged all institutions conducting such research to establish oversight committees to ensure that the new guidelines will be followed.

26 Apr 2005

Herceptin in combination with chemotherapy reduces risk of breast cancer recurrence in women with with early-stage breast cancer

Results from two clinical trials show that patients with early-stage breast cancer who received trastuzumab (Herceptin) in combination with chemotherapy had a 52 percent decrease in risk for breast cancer recurrence, compared with patients who received the same chemotherapy without the drug. The difference is statistically highly significant.

26 Apr 2005

Australian researchers develop West Nile virus treatment

A University of Queensland researcher has developed the world's first specific immunotherapy product using monoclonal antibodies for the potentially lethal West Nile virus, which causes seasonal epidemics around the globe.

26 Apr 2005

Robotic arm will help stroke survivors

A robotic arm that can be worn at home is being developed to help stroke survivors regain the ability to reach and grasp objects and perform basic tasks such as feed themselves.

26 Apr 2005

Research News and Research

Natural glucose byproduct prevents brain damage and cognitive impairment after diabetic coma

Patients' lives at risk from substandard drugs say heart specialists

Increased risk associated with combining carotid artery, coronary artery surgeries

Moderate hypothermia is a safe treatment following traumatic brain injury in children

National study to evaluate the effectiveness Targacept

First steps towards building a mind-reading device

National clinical trial examines new option for kidney cancer patients

Alcohol-impaired driving on the increase

Male therapists are just as likely as female therapists to encourage patients to admit infidelities

New, bigger low-carb potato with different taste will give consumers more choices

Promising new West Nile therapy cures disease in mice

Report reveals urgent need to improve physical health of people with Schizophrenia

Isotopes for society

Portable device to check for concussions

Quintuplets born to surrogate mother

The power of advertising means you may get medications you don't need

Guidelines for research involving human embryonic stem cells

Herceptin in combination with chemotherapy reduces risk of breast cancer recurrence in women with with early-stage breast cancer

Australian researchers develop West Nile virus treatment

Robotic arm will help stroke survivors

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo